GENELUX CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.5 USD | -3.47% |
|
-9.62% | -82.91% |
| May. 24 | Top Midday Decliners | MT |
| May. 24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 374.3 | 88.22 | - | - |
| Enterprise Value (EV) 1 | 374.3 | 88.22 | 88.22 | 88.22 |
| P/E ratio | -12.1 x | -2.71 x | -2.29 x | -2.41 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 2,202 x | 14,704 x | - | 3.09 x |
| EV / Revenue | 2,202 x | 14,704 x | - | 3.09 x |
| EV / EBITDA | - | - | - | - |
| EV / FCF | -17.6 x | -3.68 x | -2.32 x | -3.27 x |
| FCF Yield | -5.69% | -27.2% | -43.1% | -30.6% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 26,718 | 34,063 | - | - |
| Reference price 2 | 14.01 | 2.590 | 2.590 | 2.590 |
| Announcement Date | 3/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 11.07 | 0.17 | 0.006 | - | 28.55 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | - | -3.013 | -24.16 | -25.8 | -35.68 | -36.43 |
| Operating Margin | - | -27.22% | -14,214.71% | -430,066.67% | - | -127.6% |
| Earnings before Tax (EBT) 1 | - | -4.107 | -28.3 | -27.26 | -35.58 | -35.88 |
| Net income 1 | -16.38 | -5.207 | -28.3 | -27.26 | -35.58 | -35.88 |
| Net margin | - | -47.05% | -16,645.29% | -454,283.33% | - | -125.68% |
| EPS 2 | -0.6000 | -0.2100 | -1.160 | -0.9567 | -1.133 | -1.075 |
| Free Cash Flow 1 | - | - | -21.3 | -24 | -38 | -27 |
| FCF margin | - | - | -12,529.41% | -400,000% | - | -94.57% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/24/22 | 3/29/23 | 3/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.17 | - | - | - | 0.008 | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -6.462 | -5.395 | -5.307 | -7.001 | -8.115 | -5.831 | -6.024 | -6.196 | -7.031 | -6.1 |
| Operating Margin | -3,801.18% | - | - | - | -101,437.5% | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -10.36 | -5.821 | -5.345 | -6.767 | -7.85 | -6.508 | -6.633 | -6.795 | -7.031 | -6.1 |
| Net income 1 | -10.36 | -5.821 | -5.345 | -6.767 | -7.85 | -6.508 | -6.633 | -6.795 | -7.031 | -6.1 |
| Net margin | -6,096.47% | - | - | - | -98,125% | - | - | - | - | - |
| EPS 2 | -0.5300 | -0.2300 | -0.2000 | -0.2500 | -0.2900 | -0.2367 | -0.2233 | -0.2300 | -0.2100 | -0.1800 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/15/23 | 8/14/23 | 11/14/23 | 3/29/24 | 5/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | 24.5 | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | -21.3 | -24 | -38 | -27 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 0.05 | 1.03 | 0.33 | 1.2 | 3 |
| Capex / Sales | - | 0.44% | 602.94% | 5,500% | - | 10.51% |
| Announcement Date | 6/24/22 | 3/29/23 | 3/29/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.59
USD
Average target price
23.5
USD
Spread / Average Target
+807.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -82.91% | 88.22M | |
| +18.04% | 125B | |
| +13.88% | 109B | |
| -3.35% | 24.74B | |
| +2.71% | 22.67B | |
| -9.95% | 18.14B | |
| -41.48% | 16.67B | |
| -12.10% | 16.64B | |
| -0.14% | 13.45B | |
| +21.74% | 11.32B |
- Stock Market
- Equities
- GNLX Stock
- Financials Genelux Corporation
